Boston Scientific Corp. Stock Underperforms Tuesday When Compared To Competitors

Dow Jones

2025.12.02 21:37

I'm PortAI, I can summarize articles.

Boston Scientific Corp.'s stock fell 1.97% to $99.02 on Tuesday, underperforming compared to competitors like Abbott Laboratories, Medtronic PLC, and Stryker Corp. Despite a favorable market session, the stock is 9.57% below its 52-week high. Trading volume was 1.3 million below the 50-day average.

This article was automatically generated by MarketWatch using technology from Automated Insights. Shares of Boston Scientific Corp. (BSX) shed 1.97% to $99.02 Tuesday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index rising 0.25% to 6,829.37 and the Dow Jones Industrial Average rising 0.39% to 47,474.46. This was the stock's second consecutive day of losses. Boston Scientific Corp. closed 9.57% short of its 52-week high of $109.50, which the company reached on September 9th. The stock underperformed when compared to some of its competitors Tuesday, as Abbott Laboratories (ABT) fell 1.32% to $126.32, Medtronic PLC (MDT) fell 1.27% to $102.03, and Stryker Corp. (SYK) fell 1.51% to $366.68. Trading volume (7.9 M) remained 1.3 million below its 50-day average volume of 9.3 M. Data source: Dow Jones Market Data, FactSet. Data compiled December 2, 2025. This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal. (END) Dow Jones Newswires 12-02-25 1637ET